LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,000 | -99.9% | 10,000 | -99.9% | 0.00% | -100.0% |
| Q2 2021 | $14,802,000 | -71.7% | 15,000,000 | -70.3% | 0.29% | -74.5% |
| Q1 2021 | $52,330,000 | +3.1% | 50,581,000 | -5.4% | 1.13% | +4.3% |
| Q4 2020 | $50,779,000 | -0.5% | 53,485,000 | -4.8% | 1.08% | -3.8% |
| Q3 2020 | $51,013,000 | +92.0% | 56,178,000 | +84.2% | 1.12% | +80.6% |
| Q2 2020 | $26,576,000 | +539.8% | 30,500,000 | +510.0% | 0.62% | +592.2% |
| Q1 2020 | $4,154,000 | -92.1% | 5,000,000 | -91.8% | 0.09% | -91.2% |
| Q4 2019 | $52,832,000 | +0.3% | 60,954,000 | -3.4% | 1.02% | +3.6% |
| Q3 2019 | $52,698,000 | -10.2% | 63,124,000 | -7.1% | 0.99% | -13.0% |
| Q2 2019 | $58,675,000 | – | 67,972,000 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |